Owlstone Medical develops non-invasive breath tests that utilize volatile organic compound (VOC) analysis for the early detection of diseases such as cancer and respiratory conditions. This technology enables healthcare providers to identify potential health issues at an earlier stage, improving patient outcomes and reducing the need for invasive diagnostic procedures.
Funding
$27M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
VCFounders
Product
Problem
Current methods for detecting diseases like cancer and respiratory conditions often rely on invasive procedures and may not be effective for early detection. Analyzing exhaled breath offers a non-invasive alternative, but requires reliable methods for collecting and analyzing breath samples to identify relevant biomarkers.
Solution
Owlstone Medical provides tools and services for comprehensive breath analysis, enabling the discovery of volatile organic compound (VOC) biomarkers for early disease detection and precision medicine. The company's Breath Biopsy platform includes the ReCIVA Breath Sampler for reproducible breath collection, CASPER Portable Air Supply to minimize background contaminants, and Breath Biopsy OMNI analysis for high-confidence compound identification. Owlstone Medical also offers the Breath Biopsy VOC Atlas, a catalog of identified VOCs in exhaled breath, and develops EVOC Probes to target specific biological pathways.
Target Audience
Owlstone Medical serves clinical researchers, pharmaceutical companies, and healthcare providers seeking non-invasive diagnostic tools for early disease detection, precision medicine, and treatment monitoring.
Features
- ReCIVA Breath Sampler for reliable and reproducible collection of breath VOCs
- CASPER Portable Air Supply to minimize background VOCs in breath samples
- Breath Biopsy OMNI service for comprehensive VOC identification and analysis using GC-Orbitrap technology
- Breath Biopsy VOC Atlas, a catalog of identified VOCs in exhaled breath with reference ranges
- EVOC Probes for targeted assessment of specific biological pathways
- FAIMS technology for rapid and portable VOC detection
- OMED Health breath tests for diagnosing and monitoring gastrointestinal conditions
- LIBRA, a liver disease breath test using limonene as an EVOC probe
- EVOLUTION trial, a lung cancer screening test using D5-ethyl-βD-glucuronide (D5-EthGlu) as an EVOC probe